Ardelyx (ARDX) Net Cash Flow (2013 - 2026)
Ardelyx (ARDX) reported Net Cash Flow of -$36.8 million for Q1 2026, down 7.81% on a YoY basis from -$39.9 million in Q1 2025, and down 245.51% quarter-over-quarter from $25.3 million in Q4 2025.
Ardelyx (ARDX) Net Cash Flow (2013 - 2026) Analysis & Trends
Ardelyx has reported Net Cash Flow for 14 years, with the latest figure at -$36.8 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 7.81% year-over-year to -$36.8 million; the trailing twelve-month figure through Mar 2026 stood at $401000.0 (up 107.51% YoY), and the FY2025 full-year result was $3.1 million, down 92.94% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$36.8 million, down from $25.3 million in the prior quarter.
- The five-year high for Net Cash Flow was $59.2 million in Q2 2025, with the low at -$62.4 million in Q2 2023.
- Historically, Net Cash Flow has averaged -$2.4 million across 5 years, with a median of $5.5 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow soared 1306.71% — and 2023, when it plunged 1086.08%.
- Ardelyx's Net Cash Flow stood at $34.5 million in 2022, then slumped by 135.63% to -$12.3 million in 2023, then jumped by 242.34% to $17.5 million in 2024, then surged by 44.46% to $25.3 million in 2025, then tumbled by 245.51% to -$36.8 million in 2026.
- The last three Net Cash Flow figures came in at -$36.8 million (Q1 2026), $25.3 million (Q4 2025), and -$47.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -36.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.79 Mn |
| Mar 31, 2026 | -36.79 Mn |
| Dec 31, 2025 | 25.28 Mn |
| Dec 31, 2025 | 25.28 Mn |
| Sep 30, 2025 | -47.33 Mn |
| Sep 30, 2025 | -47.33 Mn |
| Jun 30, 2025 | 59.24 Mn |
| Jun 30, 2025 | 59.24 Mn |
| Mar 31, 2025 | -34.12 Mn |
| Mar 31, 2025 | -34.12 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | -12.30 Mn |
| Dec 31, 2023 | -12.30 Mn |